Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

542 words·~2 min read·/register/2024/05/06/2024-09749·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Center for Scientific Review Special Emphasis Panel;

RFA-NS-24-021: HEAL Initiative: Individual Differences in Human Pain Conditions. *Date:* June 3-4, 2024. *Time:* 8:30 a.m. to 8:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* North Bethesda Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. *Contact Person:* Mark Allen Vosvick, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, Bethesda, MD 20892, 301-402-4128, *mark.vosvick@nih.gov.* *Name of Committee:* Biobehavioral and Behavioral Processes Integrated Review Group;

Motor Function, Speech and Rehabilitation Study Section. *Date:* June 3-4, 2024. *Time:* 9:00 a.m. to 7:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Salamander Hotel, Washington, DC, 1330 Maryland Ave. SW, Washington, DC 2024. *Contact Person:* Stephanie Nagle Emmens, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,

(301)594-6604, *nagleemmenssc@csr.nih.gov* . *Name of Committee:* Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Biochemistry and Biophysics of Membranes Study Section. *Date:* June 4-5, 2024. *Time:* 8:00 a.m. to 8:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. *Contact Person:* Nuria E. Assa-Munt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 20892,

(301)451-1323, *assamunu@csr.nih.gov* . *Name of Committee:* Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neurotoxicology and Alcohol Study Section. *Date:* June 4-5, 2024. *Time:* 8:00 a.m. to 8:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Hilton Garden Inn, Bethesda, 7301 Waverly Street, Bethesda, MD 20814. *Contact Person:* John N. Stabley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,

(301)594-0566, *stableyjn@csr.nih.gov* . *Name of Committee:* Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Skeletal Muscle and Exercise Physiology Study Section. *Date:* June 4-5, 2024. *Time:* 9:00 a.m. to 10:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). *Contact Person:* Carmen Bertoni, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 805B, Bethesda, MD 20892,

(301)867-5309, *bertonic2@csr.nih.gov* . (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 30, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024-09749 Filed 5-3-24; 8:45 am]